This presentation contains the summary of documentation which is important as per standards of national accreditation board for hospital and healthcare providers.
SHARING VISION – TOWARDS BIOMEDICINE PARTNERSinemet
PharmaCon2007 Congress, Dubrovnik, Croatia "New Technologies and Trends in Pharmacy, Pharmaceutical Industry and Education" http://www.pharmacon2007.com
Abstract is available at http://www.pharmaconnectme.com
UBM Medica Diagnostic Oncology CollaborationJohn J. Currid
UBM Medica is a leading provider of relevant healthcare information and resources to today's professional healthcare providers.
Our leading brands in the fields of radiology and oncology are teaming up to provided world-class information that will have immediate impact with healthcare professionals in diagnosing and treating today's challenging oncology cases.
SHARING VISION – TOWARDS BIOMEDICINE PARTNERSinemet
PharmaCon2007 Congress, Dubrovnik, Croatia "New Technologies and Trends in Pharmacy, Pharmaceutical Industry and Education" http://www.pharmacon2007.com
Abstract is available at http://www.pharmaconnectme.com
UBM Medica Diagnostic Oncology CollaborationJohn J. Currid
UBM Medica is a leading provider of relevant healthcare information and resources to today's professional healthcare providers.
Our leading brands in the fields of radiology and oncology are teaming up to provided world-class information that will have immediate impact with healthcare professionals in diagnosing and treating today's challenging oncology cases.
Quality Use of Medicines means:
• Selecting management options wisely by:
Considering the place of medicines in treating illness and maintaining health, and
recognising that there may be better ways than medicine to manage many disorders.
• Choosing suitable medicines if a medicine is considered necessary so that the best available option is selected by taking into account:
- the individual
- the clinical condition
- risks and benefits
- dosage and length of treatment
- any co-existing conditions
- other therapies
- monitoring considerations
- costs for the individual, the community and the health system as a whole.
The Conference Board of Canada - Tuesday, April 11, 2017 - Toronto, ON
"Leveraging Change Leadership: Driving Innovation Procurement Forward"
Presentació a càrrec de Antoni Gilabert, director de l'àrea de Farmàcia i del Medicament del CSC
This presentation provides an overview of each Meaningful Use Menu Set Measure as well as its required threshold so that you can learn how to put the Meaningful Use Menu Set Measures into practice.
TAU has launched the Clinical Research Programs that make the students aware of the various drug development processes for the improved health of the society. The program is completely online and facilitates a perfect balance of self-growth as well as the welfare of the society.
The Survivor community can learn more about the state of the art in new tests available in cancer centres, which pinpoint specific types of tumours that will respond best to treatments.
This presentation has the measures to be taken for the safety of patients. It covers the 6 goals
Goal 1: Identify patients correctly
Goal 2: Improve effective communication
Goal 3: Improve the safety of high-alert medications
Goal 4: Ensure safe surgery
Goal 5: Reduce the risk of health care-associated infections
Goal 6: Reduce the risk of patient harm resulting from falls
Quality Use of Medicines means:
• Selecting management options wisely by:
Considering the place of medicines in treating illness and maintaining health, and
recognising that there may be better ways than medicine to manage many disorders.
• Choosing suitable medicines if a medicine is considered necessary so that the best available option is selected by taking into account:
- the individual
- the clinical condition
- risks and benefits
- dosage and length of treatment
- any co-existing conditions
- other therapies
- monitoring considerations
- costs for the individual, the community and the health system as a whole.
The Conference Board of Canada - Tuesday, April 11, 2017 - Toronto, ON
"Leveraging Change Leadership: Driving Innovation Procurement Forward"
Presentació a càrrec de Antoni Gilabert, director de l'àrea de Farmàcia i del Medicament del CSC
This presentation provides an overview of each Meaningful Use Menu Set Measure as well as its required threshold so that you can learn how to put the Meaningful Use Menu Set Measures into practice.
TAU has launched the Clinical Research Programs that make the students aware of the various drug development processes for the improved health of the society. The program is completely online and facilitates a perfect balance of self-growth as well as the welfare of the society.
The Survivor community can learn more about the state of the art in new tests available in cancer centres, which pinpoint specific types of tumours that will respond best to treatments.
This presentation has the measures to be taken for the safety of patients. It covers the 6 goals
Goal 1: Identify patients correctly
Goal 2: Improve effective communication
Goal 3: Improve the safety of high-alert medications
Goal 4: Ensure safe surgery
Goal 5: Reduce the risk of health care-associated infections
Goal 6: Reduce the risk of patient harm resulting from falls
RESEARCH - EDUCATIONImproving prescribing practices A pha.docxheunice
RESEARCH - EDUCATION
Improving prescribing practices: A pharmacist-led educational
intervention for nurse practitioner students
Jennifer A. Sabatino, PharmD, BCACP (Clinical Pharmacist)1, Maria C. Pruchnicki, PharmD, BCPS, BCACP, CLS
(Associate Professor)2, Alexa M. Sevin, PharmD, BCACP (Assistant Professor)2, Elizabeth Barker, PhD, CNP,
FAANP, FACHE, FNAP, FAAN, FNP-BC (Professor Emeritus of Clinical Nursing)3, Christopher G. Green, PharmD
(Specialty Practice Pharmacist)4, & Kyle Porter, MAS (Senior Consulting Research Statistician)5
1Department of Pharmacy, Memorial Hospital Medication Therapies Center, Marysville, Ohio
2Division of Pharmacy Practice and Science, The Ohio State University College of Pharmacy, Columbus, Ohio
3College of Nursing, The Ohio State University, Columbus, Ohio
4Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, Ohio
5Center for Biostatistics, The Ohio State University, Columbus, Ohio
Keywords
Pharmacotherapy; education; prescriptions;
students; pharmacists; nurse practitioner;
advanced practice nurse.
Correspondence
Maria C. Pruchnicki, PharmD, BCPS, BCACP,
CLS, Division of Pharmacy Practice and Science,
The Ohio State University College of Pharmacy,
500 West 12th Avenue, Columbus, OH 43210.
Tel: 614-292-1363; Fax: 614-292-1335; E-mail:
[email protected]
Received: 22 May 2016;
accepted: 6 January 2017
doi: 10.1002/2327-6924.12446
Previous presentations: Poster presentation at
the American Pharmacists Association Annual
Meeting, March 2014, Orlando, Florida.
Encore poster presentation at the Ohio
Pharmacists Association 136th Annual Meeting,
April 2014, Columbus, Ohio.
Podium presentation at the Ohio Pharmacy
Resident Conference, May 2014, Ada, Ohio.
Encore podium presentation at the Celebration
of Educational Scholarship “Advances in Health
Sciences Education” at The Ohio State
University College of Medicine, November
2014, Columbus, Ohio.
Encore poster presentation at the American
Pharmacists Association Annual Meeting,
March 2015, San Diego, California.
Abstract
Background and purpose: To assess impact of a pharmacist-led educational
intervention on family nurse practitioner (FNP) students’ prescribing skills, per-
ception of preparedness to prescribe, and perception of pharmacist as collabora-
tor.
Method: Prospective pre–post assessment of a 14-week educational interven-
tion in an FNP program in the spring semester of 2014. Students participated in
an online module of weekly patient cases and prescriptions emphasizing legal
requirements, prescription accuracy, and appropriate therapy. A pharmacist fa-
cilitator provided formative feedback on students’ submissions. Participants com-
pleted a matched assessment on prescription writing before and after the module,
and a retrospective postsurvey then presurvey to collect perceptions.
Conclusion: There was significant improvement in performance on error iden-
tification and demonstration of prescription.
TMLT's Risk Management team regularly conducts on-site practice reviews to help physicians address their medical liability risks. This presentation summarizes the top 10 most frequent recommendations made in 2017.
This presentation tells us about what are the medication errors and how we differentiate between them as per the National Accreditation Board for Hospital & Healthcare Providers standard for hospitals 5th Edition.
Presentation contains detailing details of medication error.
Some GIFs may not be seen.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Documentation needed by treating consultant & doctor as per standards of nabh
1. B Y – A B H I S H E K S R I V A S T A V A
B H M , M H A
Documentation required for Treating
Consultant / Physician as per National
Accreditation Board for Hospitals & Healthcare
Providers
2. Chapters of NABH 4th Edition
1. AAC – Access Assessment and Continuity of Care
2. COP – Care of Patients
3. MOM - Management of Medication
4. PRE – Patient Rights and Education
5. HIC – Hospital Infection Control
6. CQI – Continuous Quality Improvement
7. ROM – Responsibility of Management
8. FMS – Facility Management and Safety
9. HRM – Human Resource Management
10. IMS – Information Management System
PatientCenteredOrganizationCentered
3. Chapters of NABH 4th Edition
1. AAC – Access Assessment and Continuity of Care
2. COP – Care of Patients
3. MOM - Management of Medication
4. PRE – Patient Rights and Education
5. HIC – Hospital Infection Control
6. CQI – Continuous Quality Improvement
7. ROM – Responsibility of Management
8. FMS – Facility Management and Safety
9. HRM – Human Resource Management
10. IMS – Information Management System
PatientCenteredOrganizationCentered
4. AAC – Access Assessment and Continuity of
Care
Initial Assessment and Care Plan.
Documented Assessment – Every Patient every day
until the discharge
Notes should Include – Current Status of patient,
Detailed assessment, Medications, Critical Results if
any
5. COP – Care of Patient
Uniform Care Policy
Standard Treatment Protocol
Daily Doctor’s Assessment
Referral of patient documentation
Informed Consent for every procedure
Consents should include the information about the risk &
benefits, alternatives of treatment and risk & benefits of doing
nothing.
Infection Control Measures
Patient Safety Measures
Rational Use of Blood and Blood Product
Identification and Reporting of community emergency and
epidemics
6. MOM – Management of
Medication
Monitoring of patient under anaesthesia
Discharge criteria from recovery area
Surgical Patient - Planned Surgery
Assurance of surgical procedures
Nutritional Screening
Monitoring of patient after medication administration
(Including Anaesthesia)
Reporting of medication error
Documentation of narcotics drug and psychotropic
medications
Use of Implantable prosthesis
Verbal Orders
7. PRE – Patient Rights and
Education
Effective Communication & Documentation of same
with patient and family
Patient Complaints escalation to operations or
patient welfare department
8. HIC – Hospital Infection
Control
Rational use of antibiotics
To make strong grip over antibiotics usage among
patients, quality department will introduce antibiotic
justification forms to prevent the irrational and over
use of antibiotics
9. CQI – Continues Quality
Improvement
Quality Indicators
1. Time of Initial Assessment by doctors
2. Percentage of cases wherin care plan with desired outcome documented
and signed
3. Percentage of Medication Errors
4. Percentage of admission with adverse drug reaction
5. Percentage of medication chart with error prone abreviations
6. Percentage of patients receiving high risk medications developing
Adverse Drug Reactions
7. Percentage of modification of anaesthesia plan
8. Percentage of unplanned ventilation following anaesthesia
9. Percentage of Adverse anaesthesia event
10. Anaesthesia related mortality rate
11. Percentage of unplanned return to OT
12. Percentage of resheduling of OT
10. CQI – Continues Quality
Improvement
1. Percentage of adherence to surgical safety checklist
2. Percentage of cases who received appropriate prophylactic
antibiotic within specified time
3. Re- Exploration Rate
4. Percentage of Transfusion Reaction
5. Mortality Rate
6. Return to ICU within 48 Hours
7. Return to Emergency within 72 hour with similar presenting
complaints
8. Re-Intubation Rate
9. Incidence of Fall
10. Average Length of Stay
11. Percentage of medical records not having discharge summary